Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors
NCT02698254Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2016
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Highest grade of central nervous system (CNS) necrosis at 6 months. Started Jul 2016; status: active, not recruiting.
Beyond the preview
Go deeper on NCT02698254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698254.